Blueshift Asset Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-8,740
Closed -$516K 514
2025
Q2
$516K Buy
+8,740
New +$565K 0.16% 179
2024
Q2
Sell
-6,711
Closed -$360K 367
2024
Q1
$360K Buy
+6,711
New +$361K 0.19% 171
2022
Q2
Sell
-3,713
Closed -$274K 801
2022
Q1
$274K Buy
+3,713
New +$258K 0.03% 643
2019
Q1
Sell
-17,715
Closed -$767K 801
2018
Q4
$767K Buy
+17,715
New +$884K 0.14% 230

Other funds holding GMED

Blueshift Asset Management's GMED Position: Q3 2025 in Review

Blueshift Asset Management sold out of Globus Medical (GMED) in Q3 2025, closing a stake of 8,740 shares — an estimated $516K sold.

Blueshift Asset Management first reported a position in GMED in Q4 2018 and held it in 4 quarters. The position peaked at $767K in Q4 2018. 489 funds tracked by Wall St. Rank hold GMED as of Q3 2025.

  • Blueshift Asset Management reported no remaining Globus Medical position as of Q3 2025 after selling out during the quarter.
  • Blueshift Asset Management sold 8,740 Globus Medical shares in Q3 2025, an estimated $516K.
  • Blueshift Asset Management first reported a position in Globus Medical in Q4 2018 and held it in 4 quarters.
  • Blueshift Asset Management's Globus Medical position peaked at $767K in Q4 2018.
  • 489 funds tracked by Wall St. Rank held Globus Medical as of Q3 2025.

Based on Blueshift Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.